SANGAMO THERAPEUTICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $82.89 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-03-13
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $82.89M.
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $335.61M.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $294.96M.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $309.15M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2023-12-31 | $82.89M 10-K · filed 2024-03-13 |
| 2023-03-31 | $335.61M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $294.96M 10-K · filed 2024-03-13 |
| 2022-09-30 | $309.15M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $318.28M 10-Q · filed 2022-11-03 |
| 2022-03-31 | $334.52M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $375.34M 10-K · filed 2024-03-13 |
| 2021-09-30 | $406.02M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $445.46M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $469.42M 10-Q · filed 2022-08-04 |
| 2020-12-31 | $497.37M 10-K · filed 2024-03-13 |
| 2020-09-30 | $520.88M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $511.21M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $394.42M 10-Q · filed 2021-08-05 |
| 2019-12-31 | $432.74M 10-K · filed 2023-02-23 |
| 2019-09-30 | $419.33M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $445.75M 10-Q · filed 2020-11-04 |
| 2019-03-31 | $329.18M 10-Q · filed 2020-08-05 |
| 2018-12-31 | $367.26M 10-K · filed 2022-02-24 |
| 2018-09-30 | $379.91M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $387.87M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $182.37M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $187.90M 10-K · filed 2021-02-24 |
| 2016-12-31 | $136.19M 10-K · filed 2020-02-28 |
| 2015-12-31 | $192.44M 10-K · filed 2019-03-01 |